Patient-health care provider relationship: How can it impact on APS (Hughes' syndrome) adherence to treatment?

Lupus

Volumn 23, Issue 12, 2014, Pages 1265-1268

  Levy, R A ^a,b   Signorelli, F ^c,d  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b Centro de Imunoterapia de Ipanema CITIPA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

Author keywords

anticoagulation; antiphospholipid syndrome; Treatment adherence

Indexed keywords

ANTICOAGULANT AGENT; ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; HEALTH CARE PERSONNEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTERPERSONAL COMMUNICATION; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PREGNANCY; TREATMENT OUTCOME; DOCTOR PATIENT RELATION; FEMALE; HOSPITAL INFORMATION SYSTEM;

ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEALTH PERSONNEL; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INTERNATIONAL NORMALIZED RATIO; MEDICATION ADHERENCE; PHYSICIAN-PATIENT RELATIONS; POINT-OF-CARE SYSTEMS; PREGNANCY;

EID: 84908702880     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314536480     Document Type: Conference Paper

References (18)

1. Hartzband P, Groopman J. Keeping the patient in the equation - humanism and health care reform. N Engl J Med. 2009 ; 361: 554-555
2. de Abreu MM, Gafni A, Bosi Ferraz M. Development and testing of a decision board to help clinicians present treatment options to lupus nephritis patients in Brazil. Arthritis Care Res. 2009 ; 61: 37-45
3. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999 ; 47: 555-567
4. Danowski A, Rego J, Kakehasi AM, et al. Guidelines for the treatment of antiphospholipid syndrome. Rev Bras Reumatol. 2013 ; 53: 184-192
5. Hughes GR. Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janeiro, October 2013. Lupus. 2014 ; 23: 400-406
6. Taraborelli M, Andreoli L, Tincani A. Much more than thrombosis and pregnancy loss: The antiphospholipid syndrome as a 'systemic disease'. Best Pract Res Clin Rheumatol. 2012 ; 26: 79-90
7. Erkan D, Kozora E, Lockshin MD. Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology. 2011 ; 18: 93-102
8. Arnson Y, Shoenfeld Y, Alon E, et al. The antiphospholipid syndrome as a neurological disease. Sem Arthritis Rheum. 2010 ; 40: 97-108
9. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol. 1992 ; 19: 508-512
10. de Jesus GR, dos Santos FC, Oliveira CS, et al. Management of obstetric antiphospholipid syndrome. Curr Rheumatol Rep. 2012 ; 14: 79-86
11. Arnaud L, Mathian A, Ruffatti A, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: An international and collaborative meta-analysis. Autoimmun Rev. 2014 ; 13: 281-291
12. Klack K, de Carvalho JF. Vitamin K: Metabolism, sources and interaction with the anticoagulant warfarin. Rev Bras Reumatol 2006; 46: 398-406.
13. Bussey HI, Bussey M, Bussey-Smith KL, et al. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: A pilot study. Pharmacotherapy. 2013 ; 33: 1136-1146
14. Petrie KJ, Perry K, Broadbent E, et al. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012 ; 17: 74-84
15. Dignan R, Keech AC, Gebski VJ, et al. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial. Int J Cardiol. 2013 ; 168: 5378-5384
16. Barbará F, Levy R, Signorelli F. Website to monitoring patients with antiphospholipid syndrome. Abstract 0277 presented at 14th International Congress on Antiphospholipid Antibodies and 4th Latin American Congress of Autoimmunity, Rio de Janeiro, 2013.
17. Lee A, Crowther M. Practical issues with vitamin K antagonists: Elevated INRs, low time time-in-therapeutic range, and warfarin failure. J Thromb Thrombolysis. 2011 ; 31: 249-258
18. Erkan D, Aguiar CL, Andrade D, et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on antiphospholipid syndrome treatment trends. Autoimmun Rev. 2014 ; 13: 685-696